Encephalomyelitis and Medical Marijuana: Types and Research

65 minute read
0
(0)

Encephalomyelitis means inflammation of both the brain and the spinal cord, and the same word is used for several different diseases: acute disseminated encephalomyelitis (ADEM), myalgic encephalomyelitis (ME/CFS), an old name for multiple sclerosis, rare autoimmune forms and a laboratory model called EAE. For medical marijuana the evidence is narrow. In animal and cell studies of that lab model, cannabinoids such as CBD and THC softened signs of inflammation, but none of the research behind this page tested people with any form of encephalomyelitis.

Based on peer-reviewed laboratory studies in animals and cells; every study is listed below

After ADEM, living with ME/CFS, or told it might be MS: where to start

Brain fog that will not lift. Legs that feel heavy by midafternoon. A crash that lasts two days after a short walk to the mailbox. And three doctors who wrote three different names on three different forms. People land on the word encephalomyelitis after months of tests, often while the people around them see someone who looks fine.

Part of the confusion is the word itself, which points to very different illnesses. Part of it is cannabis: the questions about it come wrapped in stigma, and the research is easy to over-read. Pick the line that sounds like you and start there; the rest of this guide sorts the types, the evidence and the conversation with your physician.

I live with ME/CFS

Exhaustion after effort, sleep that does not restore. None of the cannabis studies cited here looked at ME/CFS, and the page says so plainly.

What ME/CFS is · What to ask

A doctor mentioned MS

Encephalomyelitis disseminata is an older name for multiple sclerosis, and MS is where cannabis has actually been studied in people.

Compare the types · Cannabis and MS

I already use cannabis

Then the useful questions are about your other medicines, the form you use and what to tell your neurologist.

Interactions · Forms of use

What is encephalomyelitis? Definition, pronunciation and ICD-10 codes

Encephalomyelitis is inflammation of the brain and the spinal cord at the same time. The inflammation can be triggered by an infection, by the immune system attacking the coating of nerve fibers (myelin), or, rarely, by a reaction after a vaccine. Symptoms depend on where the inflamed areas sit: confusion, weakness, numbness, problems with balance or vision [2].

The word, broken down

  1. encephalo-brain
  2. myel-spinal cord
  3. -itisinflammation

How to pronounce encephalomyelitis

en-SEF-uh-loh-MY-uh-LY-tis (stress on SEF and LY)

ICD-10 codes for encephalomyelitis

There is no single code for encephalomyelitis. In the United States the code on your record depends on which disease was diagnosed. The multiple sclerosis code changed recently: since October 2025 the old single code G35 is split by course of the disease [3].

ICD-10-CM codes used in the United States, fiscal year 2026 [3]
CodeWhat it coversType
G04.00Acute disseminated encephalitis and encephalomyelitis, unspecifiedADEM
G04.01Postinfectious acute disseminated encephalitis and encephalomyelitisADEM after an infection
G04.02Postimmunization acute disseminated encephalitis, myelitis and encephalomyelitisADEM after a vaccine
G04.81Other encephalitis and encephalomyelitisOther named forms
G04.90Encephalitis and encephalomyelitis, unspecifiedCause not stated
G93.32Myalgic encephalomyelitis/chronic fatigue syndromeME/CFS
G35.A to G35.DMultiple sclerosis: relapsing-remitting, primary progressive, secondary progressive, unspecifiedMS (encephalomyelitis disseminata)

→ Which of these diseases is yours: compare the types

Which encephalomyelitis do you mean? ADEM, ME/CFS, MS, autoimmune and lab EAE compared

Seven different things travel under this one word, and they have little in common beyond the name. Pick the one written on your paperwork; each panel says who gets it, how it runs, how it is treated and whether anyone has studied cannabis for it.

Acute disseminated encephalomyelitis (ADEM)

Who it affects
Mostly children, adults less often, usually days to weeks after a viral or bacterial infection and rarely after a vaccine.
How it runs
One sudden attack with fever, confusion and widespread inflammation of myelin; most people recover over weeks to months, some relapse.
Main treatment
High-dose steroids in hospital, then IVIG or plasma exchange if needed [1].
Cannabis research
No studies in people with ADEM.

Recovery and relapse after ADEM

Myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS)

Who it affects
Adults and teenagers of any background, often after an infection; women more often than men.
How it runs
Long-lasting, often for years, with good and bad stretches; symptoms get worse after physical or mental effort [4].
Main treatment
No approved cure; care manages symptoms: pacing activity, sleep, dizziness on standing, pain.
Cannabis research
No studies in people with ME/CFS among those cited here.

More about ME/CFS

Encephalomyelitis disseminata (multiple sclerosis)

Who it affects
Mostly adults between 20 and 50 [5]; “encephalomyelitis disseminata” is an older European name for MS.
How it runs
Lifelong, most often in relapses and remissions, sometimes steadily progressive [5].
Main treatment
Disease-modifying therapies, steroids for relapses, rehabilitation and symptom care.
Cannabis research
Human studies exist, mainly on spasticity and pain.

Cannabis and multiple sclerosis

Autoimmune encephalomyelitis (MOGAD, NMOSD)

Who it affects
Children and adults whose blood carries antibodies against MOG (MOGAD) or aquaporin-4 (NMOSD).
How it runs
Attacks on the optic nerves, spinal cord or brain; can return, so long-term prevention matters.
Main treatment
Steroids and plasma exchange for attacks, immune-suppressing drugs to prevent new ones.
Cannabis research
No studies in people.

How the antibody tests work

Paraneoplastic encephalomyelitis

Who it affects
Adults with a cancer, often not yet found, that makes the immune system attack the nervous system.
How it runs
Develops over weeks to months; can come before the cancer is diagnosed.
Main treatment
Finding and treating the cancer, plus immune therapy.
Cannabis research
No studies in people.

Cannabis and cancer symptoms

Progressive encephalomyelitis with rigidity and myoclonus (PERM)

Who it affects
Rare; adults, often with antibodies against the glycine receptor. It belongs to the stiff person spectrum.
How it runs
Muscle stiffness, painful spasms, sudden jerks (myoclonus) and brainstem symptoms that build up over weeks.
Main treatment
Immune therapy and medicines that relax muscles and calm spasms.
Cannabis research
No studies in people.

Cannabis and muscle spasms

Experimental autoimmune encephalomyelitis (EAE)

Who it affects
Laboratory mice and rats only. No person has EAE.
How it runs
Researchers trigger it with a myelin protein fragment; it is used as a model of MS.
Main treatment
Not applicable: it exists to test ideas.
Cannabis research
Animal model only. Every cannabis study on this page used it.

What those studies found

Show all types as a table
Types of encephalomyelitis compared
TypeWhoCourseMain treatmentCannabis data
ADEMMostly children, after infectionOne attack, usually recoverySteroids, IVIG, plasma exchangeNone in people
ME/CFSTeens and adults, often after infectionChronic, fluctuatingSymptom care, pacingNone in people
MS (disseminata)Adults 20 to 50 [5]Lifelong, relapsing or progressiveDisease-modifying therapyHuman studies exist
Autoimmune (MOGAD, NMOSD)Children and adults with antibodiesAttacks, may returnSteroids, immune therapyNone in people
ParaneoplasticAdults with a cancerWeeks to monthsTreat the cancer, immune therapyNone in people
PERMRare, adultsBuilds over weeksImmune therapy, muscle relaxantsNone in people
EAELab mice and ratsInduced in the labNot applicableAnimal studies only

Encephalomyelitis in horses, dogs and birds: a different disease

Equine encephalomyelitis (eastern, western and Venezuelan, shortened to EEE, WEE and VEE) is caused by viruses that mosquitoes carry, and the eastern type can infect people too [6]. Horses are vaccinated against it, often with combination shots that also cover rhinopneumonitis and influenza; which vaccine and when is a question for your veterinarian. Dogs can develop encephalomyelitis from distemper, and avian encephalomyelitis is a viral disease of young poultry.

None of this has anything to do with medical cannabis for people. Cannabis is not a treatment for animals, and THC is toxic to dogs: wobbliness, drooling and urine leakage after a dog gets into an edible need a call to a vet or an animal poison line [7].

→ Symptoms side by side · Cannabis and multiple sclerosis

Myalgic encephalomyelitis (ME/CFS): what it is, why it’s called that and how long it lasts

Myalgic encephalomyelitis, also called chronic fatigue syndrome or ME/CFS, is a long-term illness that affects many body systems at once. Its signature is post-exertional malaise (PEM): symptoms get worse after physical or mental effort, often a day later, and the crash can last days [4].

What happens in ME/CFS

Besides PEM, the core features named in the 2015 diagnostic criteria are sleep that does not refresh, problems with thinking and memory (brain fog), and dizziness or a racing heart when standing up, called orthostatic intolerance [8]. Pain in muscles and joints is common. Many people are housebound at their worst.

Why it’s called that

“Myalgic” means muscle pain and “encephalomyelitis” was the guess, decades ago, that the brain and spinal cord were inflamed. That inflammation has never been shown consistently, which is why the name chronic fatigue syndrome came into use and why the two now travel together. The WHO classifies it as a neurological disease, and the US code is G93.32 [3].

How long does myalgic encephalomyelitis last?

Usually for years. It tends to move in waves, with better and worse months, and some people improve a great deal while full recovery is uncommon in adults [4]. ME/CFS is not contagious and is not known to shorten life by itself; in the United States it can be the basis of a disability claim when it stops a person from working. Care focuses on pacing activity to stay below the crash point, treating sleep, pain and orthostatic symptoms, and adjusting work and school.

Encephalomyelitis vs encephalitis: what is the difference?

Encephalitis is inflammation of the brain alone; encephalomyelitis is inflammation of the brain and the spinal cord together. Myelitis, the third relative, involves only the spinal cord. Doctors often file them under one heading, which is why the US code group G04 is titled “encephalitis, myelitis and encephalomyelitis” [3].

Brain Spinal cord

Encephalomyelitis: the brain and the spinal cord are inflamed.

Three related diagnoses, side by side
EncephalitisMyelitisEncephalomyelitis
What is inflamedBrainSpinal cordBrain and spinal cord
Typical causesViruses (herpes, mosquito-borne), autoimmune antibodiesInfections, MS, NMOSD, MOGADImmune reaction after infection (ADEM), autoimmune disease
Typical symptomsFever, headache, confusion, seizuresLeg weakness, numbness below a level, bladder problemsA mix of both, often with balance and vision problems

What causes encephalomyelitis? Infections, rare vaccine reactions and autoimmunity

Most encephalomyelitis is the immune system overreacting, usually after an infection; the cause depends on the type [1].

ADEM

Follows a viral or bacterial infection by days to weeks, more often in children. Rarely it follows a vaccine, which has its own code, G04.02 [3]. Often no trigger is found.

Autoimmune forms

Antibodies against MOG or aquaporin-4 attack myelin or supporting cells. In paraneoplastic forms, the immune response to a hidden cancer turns on the nervous system.

ME/CFS

Often starts after an infection, including COVID-19, though some people cannot name a trigger. Why it persists is still being researched [4].

→ What the symptoms look like

Encephalomyelitis symptoms: ADEM, ME/CFS and MS side by side

ADEM comes on suddenly with fever and confusion, ME/CFS builds into long-lasting exhaustion that worsens after effort, and MS (encephalomyelitis disseminata) comes in episodes of numbness, weakness or blurred vision. Choose one type to read its column alone.

Encephalomyelitis symptoms by type
AreaADEMME/CFSMS
How it startsOver hours to days, often after an infectionOften after an infection, then does not resolveAn episode over days, then partial or full recovery
Core symptomsFever, headache, vomiting, drowsinessCrash after effort (PEM), unrefreshing sleepFatigue, numbness or tingling, weakness
Thinking and moodConfusion, irritability, in severe cases comaBrain fog, slow processing, poor memorySlowed thinking, low mood
Movement and feelingUnsteady walking (ataxia), weakness, numbnessMuscle and joint pain, heavy limbsStiffness and spasms, balance problems
VisionBlurred or lost vision from optic nerve inflammationLight sensitivity, trouble focusingPainful blurred vision in one eye (optic neuritis)
CourseUsually one attackChronic, in wavesLifelong, relapsing or progressive

The split that matters most is acute against chronic. A sudden change over hours or days, with fever, confusion, a seizure or new loss of vision, is an emergency and belongs in hospital. Symptoms that have been with you for months are a matter for planned care: a neurologist, a diagnosis that holds up, and a plan for the symptoms that bother you most.

→ Sudden new symptoms: the 911 signs

Is my kind of encephalomyelitis one where cannabis is even worth asking about?

Twelve short questions about your diagnosis, how you feel right now and the medicines you take. You get a plain reading of what your answers point to, what research has and has not shown for that situation, and what to bring to a physician. This is not a diagnosis.

12 questions · about a minute · your answers stay in this browser

Question 1 of 12

Is any of this happening right now or started in the last few days?

Answer this one exactly as it is. It changes what the result tells you.

How is encephalomyelitis diagnosed? MRI, spinal tap, antibody tests and what else it could be

There is no single test. Physicians put together a brain and spine MRI, a spinal fluid sample and blood antibody tests, and rule out infection, which together tell ADEM, MS, MOGAD, NMOSD and infectious encephalitis apart [1]. ME/CFS is the exception: it is diagnosed from symptoms against set criteria, because no scan or lab test confirms it [8].

MRI

Shows where the inflammation sits. Many large, similar-age patches suggest ADEM; scattered older and newer spots suggest MS.

Lumbar puncture

A sample of spinal fluid (CSF) checks for infection, extra white cells and oligoclonal bands, which point toward MS.

Antibody blood tests

MOG-IgG and AQP4-IgG identify MOGAD and NMOSD, which are treated differently from MS.

EEG

Records the brain’s electrical activity when there is confusion or a seizure, and shows whether seizures continue unseen.

ME/CFS criteria

The 2015 criteria ask for reduced activity for six months or more, PEM, unrefreshing sleep, plus brain fog or orthostatic intolerance [8].

Reading your MRI report

Reports are written for other doctors. Open the terms you see on yours.

Demyelination

Damage to myelin, the fatty coating that lets nerve signals travel fast. It is the shared feature of ADEM, MS and the antibody diseases.

T2 or FLAIR hyperintensities

Bright spots on two common MRI settings. They mark tissue with extra water, from inflammation, old scarring or, in older adults, small vessel changes. Location and shape matter more than the brightness.

Gadolinium enhancement

Spots that light up after contrast dye are active right now, because the barrier around blood vessels is leaking. Non-enhancing spots are older.

Lesion

Any area that looks different from healthy tissue. The word alone does not say how serious it is.

White matter and gray matter

White matter is the wiring, rich in myelin; gray matter holds the nerve cell bodies. ADEM often touches both, including deep gray matter such as the thalamus.

Oligoclonal bands

A spinal fluid finding, not an MRI one, but it appears in the same reports: antibody bands made inside the nervous system. Common in MS, less so in ADEM.

What else it could be

The main question after a first attack is whether it was a one-time ADEM or the start of something that returns. A first MS attack, MOGAD and NMOSD can all look like ADEM at the start; the antibody tests and a repeat MRI months later usually settle it. Infectious encephalitis, especially herpes, is ruled out early because it needs antiviral treatment right away. For long-lasting fatigue, thyroid disease, anemia, sleep apnea and depression are checked before ME/CFS is diagnosed.

→ How each type is treated

How is encephalomyelitis treated? Steroids, IVIG, plasma exchange and symptom care

Acute encephalomyelitis is treated by calming the immune attack quickly, in hospital. For ADEM the usual sequence is [1]:

  1. High-dose steroids through a vein, usually methylprednisolone for several days, often followed by a tapering course of tablets.
  2. IVIG, antibodies pooled from donors, when steroids are not enough or cannot be used.
  3. Plasma exchange, which filters harmful antibodies out of the blood, for severe attacks that do not respond.
  4. Rehabilitation: physical, occupational and speech therapy while the nervous system recovers.

Multiple sclerosis is managed for the long term with disease-modifying therapies that reduce relapses, plus treatment of spasticity, bladder symptoms, pain and fatigue; the evidence on cannabis for those symptoms is on cannabis and multiple sclerosis. Antibody diseases such as MOGAD and NMOSD often need long-term immune therapy to prevent new attacks.

ME/CFS has no approved cure, so care is about symptoms: pacing energy to avoid crashes, improving sleep, treating dizziness on standing with fluids, salt or medicines, and managing pain [4]. Graded exercise that pushes through PEM is no longer recommended.

Encephalomyelitis prognosis: recovery, relapse and life after the acute phase

The outlook depends almost entirely on the type: ADEM usually ends in good recovery, MS is lifelong, and ME/CFS tends to last years with ups and downs.

After ADEM

Most children recover fully or nearly fully over weeks to months; adults recover more slowly [1]. A minority have another attack (multiphasic ADEM) or later turn out to have MS or MOGAD, which is why follow-up MRIs matter.

Encephalomyelitis disseminata (MS)

A lifelong condition whose course varies widely between people. Modern treatment has changed the outlook a great deal; the details are on our MS page.

ME/CFS

Long-lasting and fluctuating. Some people improve substantially, especially with early pacing; others stay limited for years. It is not considered progressive in the way MS can be.

Support does not have to come only from the clinic. Patient organizations publish plain-language guides and run support groups: Encephalitis International for encephalitis and ADEM [9], the National Multiple Sclerosis Society for MS [5], and the CDC’s ME/CFS pages for patients and families [4].

→ Why cannabinoids are studied at all

Why researchers test cannabinoids in encephalomyelitis models: CB1, CB2 and immune cells

Researchers test cannabinoids here because the body’s own cannabinoid system sits on both sides of the problem: on nerve cells that are damaged and on the immune cells that do the damage. The endocannabinoid system is a set of signaling molecules the body makes itself, the receptors they bind to, and the enzymes that break them down. THC and CBD from the plant act on parts of the same system.

CB1: mostly on nerve cells

CB1 receptors are dense in the brain and spinal cord. In mice with the lab disease, losing CB1 changed how much IFN-gamma, an inflammatory signal, different cells produced, and the effect pointed in different directions depending on the cell type [10].

CB2: mostly on immune cells

CB2 sits on immune cells and on microglia, the brain’s own immune cells. In mice, switching CB2 on with a selective drug reduced Th17 cells, a type of inflammatory T cell, and fewer immune cells built up in the brain and spinal cord [11].

Almost all of this work uses EAE, experimental autoimmune encephalomyelitis. Researchers inject mice or rats with a fragment of a myelin protein, the animal’s immune system attacks its own myelin, and the animal develops weakness and paralysis that is scored on a simple scale. It is used as a model of multiple sclerosis because it reproduces the immune attack on myelin, not because people get it.

The compounds tested include CBD alone, THC and CBD together, a modified form of cannabigerol (CBG) called VCE-003, and drugs that act on CB2 only. Palmitoylethanolamide (PEA) turns up as well; it is a fat-like molecule the body makes that behaves like an endocannabinoid, not a cannabis compound, and it is kept separate below.

What the research shows, from strongest to weakest: animal and cell studies, no human trials

Every study on cannabinoids and encephalomyelitis cited here was done in animals or in cells, and none tested people. Evidence is usually ranked from pooled analyses of trials at the top down to laboratory work at the bottom; for this condition, only the bottom step is occupied.

  1. Systematic reviews and meta-analysesNone for encephalomyelitis
  2. Randomized trials in peopleNone for encephalomyelitis
  3. Observational studies in peopleNone for encephalomyelitis
  4. Case reportsNone for encephalomyelitis
  5. Animal and cell studiesEvery study on this page

The lab results lean positive: in most of them, animals given a cannabinoid had milder disease than untreated animals. Read that as a reason to run human trials, which have not been done for ADEM, ME/CFS or autoimmune encephalomyelitis.

Browse the studies

Not every study here tested cannabis. Filter by what was given to the animals; the ones marked as other substances touch the cannabinoid system but are not cannabis products.

2021 · Animal experiment · mice with EAE [12]

Oral CBD and the early immune response

Mice received 75 mg/kg of CBD by mouth for 5 days after the disease was triggered and were followed for 18 days [12]. CBD reduced disease severity, which went together with an early drop in IFN-gamma producing CD8+ T cells in the spleen and a modest reduction of inflammation in the nervous system.

2019 · Animal and cell study · mice with EAE [13]

CBD and gene activity in attacking T cells

In T cells from mice with EAE, CBD at 10 mg/kg changed chemical marks on DNA packaging and small regulatory RNAs [13]. It suppressed 74 microRNAs that the disease had switched on and restored 23 that it had switched off [13].

2019 · Animal experiment · mice with EAE [14]

THC and CBD together, and the gut

A 1:1 combination of THC and CBD, 10 mg/kg each by injection, made the disease milder [14]. The treated mice had fewer mucus-degrading gut bacteria, less bacterial toxin reaching the brain and lower levels of inflammatory signals (IL-17A, IFN-gamma).

2015 · Animal experiment · mice with EAE [15]

A 1% CBD cream on the skin

Daily 1% CBD cream rubbed on the hind limbs lowered the average disease score from 5.0 in untreated mice to 1.5 over 28 days [15]. A result in mice with a specific lab cream, not a finding about creams sold to people.

2014 · Animal and cell study · mice with EAE [16]

VCE-003, a modified cannabigerol

This lab-made derivative of CBG, given at 5 mg/kg a day by injection, acted through CB2 and PPAR-gamma receptors, damped T cell growth and inflammatory signals, and protected the mice from the disease [16].

2021 · Animal and cell study · mice lacking CB1 [10]

The CB1 receptor and IFN-gamma: a mixed result

Mice without CB1 made more IFN-gamma in some immune cells during EAE but less in T cells stimulated directly. The receptor’s role depends on the cell, so blocking or boosting it is not simply good or bad.

2014 · Animal experiment · mice with EAE [11]

A drug that switches on CB2 only

The selective CB2 agonist Gp1a reduced inflammatory Th17 cells outside the nervous system and limited how many immune cells reached the brain and spinal cord, making the disease milder.

2022 · Animal experiment · 56 rats [17]

Exercise and royal jelly, not cannabis

Five weeks of endurance training plus royal jelly at 50 or 100 mg/kg raised CB1 receptor activity in the hippocampus and the pain threshold in rats with EAE [17]. Included because it measured the cannabinoid system; nothing cannabis-based was given.

2021 · Animal experiment · mice with EAE [18]

Crotalphine, a snake venom peptide

This peptide eased pain and nerve inflammation in mice, partly by activating CB2 receptors and releasing the body’s own opioids. A different substance that happens to use a cannabinoid receptor.

2019 · Animal experiment · 8 mice per group [19]

PEA with luteolin

A combination of palmitoylethanolamide, an endocannabinoid-like molecule, and the plant compound luteolin lowered disease scores and inflammation markers in mice. Not a cannabis product.

2019 · Animal and cell study · 12 mice per group [20]

A microRNA that drives brain inflammation

Mice lacking the regulator Mir223 had milder EAE because their microglia cleared debris more actively. A study of immune wiring with no cannabinoid treatment at all.

When were these studies published?

How to read it: each dot is one study, stacked above the year it was published. Dark filled dots tested a cannabis compound, lighter filled dots studied a cannabinoid receptor, and hollow gray dots tested another substance.

The cannabis-compound studies span 2014 to 2021 [16] [12], and the most recent work in this set, from 2022, did not test cannabis at all [17].

Show as a table
YearWhat was testedGroup
2014VCE-003, modified CBG [16]Cannabis compound
2014Selective CB2 agonist [11]Receptor study
20151% CBD cream [15]Cannabis compound
2019CBD and T cell genes [13]Cannabis compound
2019THC and CBD 1:1 [14]Cannabis compound
2019PEA with luteolin [19]Other substance
2019Mir223 deletion [20]Other substance
2021Oral CBD [12]Cannabis compound
2021CB1 receptor deletion [10]Receptor study
2021Crotalphine [18]Other substance
2022Exercise and royal jelly [17]Other substance

→ Cannabis and multiple sclerosis, where studies in people exist

What the lab studies did: doses, models and what changed in the animals

In the clearest result, mice treated with a CBD cream ended with a far lower disease score than untreated mice. None of these studies measured how much a person’s symptoms change, so every number below describes animals.

Doses given to animals in these studies. Not a human dose, and not convertible into one.
What was givenAnimalRouteHow longStudy
CBD 75 mg/kgMiceBy mouth5 days, followed for 182021 [12]
CBD 10 mg/kgMiceInjectionCells collected at day 72019 [13]
THC 10 mg/kg plus CBD 10 mg/kg (1:1)MiceInjectionDuring the disease course2019 [14]
1% CBD creamMiceOn the skinDaily, 28 days2015 [15]
VCE-003 (modified CBG) 5 mg/kg a dayMiceInjectionDaily during disease2014 [16]

Two things stand out. The doses are measured per kilogram of a mouse and mostly injected into the belly, which says nothing about a tincture or a gummy taken by a person. And the products were purified compounds, not plant extracts from a dispensary, where THC and CBD content varies between batches.

Results were not all positive: the negative and mixed studies

The CB1 study is the clearest warning against a simple story. Removing the receptor raised the inflammatory signal IFN-gamma in some immune cells and lowered it in others [10]. Acting on the cannabinoid system can push inflammation in either direction depending on the cell, the receptor and the timing.

Beyond that, the wider literature contains lab studies where cannabinoids did not help or made no clear difference. Positive results in animals are published more readily than negative ones, a pattern called publication bias, so a stack of positive mouse papers looks stronger than it is.

Animal work also has built-in limits. Most of these experiments tested a single dose, in young animals, in a form of EAE that strikes once and then settles. Human encephalomyelitis is usually a different disease, in older bodies, lasting months or years, and drugs that worked in EAE have often failed in people.

What science doesn’t know yet about cannabis and encephalomyelitis

The open questions here are larger than the findings, and most of them come straight from the study authors.

  • Whether it does anything in people. No study cited here included a person with ADEM, ME/CFS, autoimmune or paraneoplastic encephalomyelitis.
  • Whether the model fits. The common form of EAE strikes once and settles, while chronic progressive MS does not, which limits how far results carry over [19].
  • What dose, for how long. Several experiments tested one dose only, with no data on long-term toxicity or on translating animal doses to people [12].
  • Whether damaged myelin repairs. Genes linked to repair moved, but myelin proteins themselves did not change measurably in the animals [19].
  • How the effect works in detail. Authors list cell types and pathways they could not pin down [10] [13].
  • Side effects and interactions in this population. None of these studies recorded them in people, because none involved people.
  • Children. ADEM is most common in children, and there is no research on cannabinoids for it at any age.

→ What is known about safety

Is cannabis safe with encephalomyelitis? Balance, brain fog, seizures and who should avoid it

Nobody has measured cannabis safety in people with encephalomyelitis: the studies on this page involved animals only. What is known comes from the prescription labels of cannabinoid medicines and from general use, and several of those effects land on exactly the symptoms this condition causes.

  • Balance and falls. THC can cause dizziness and unsteadiness [21]. With ataxia or weak legs after ADEM or in MS, that adds to an existing fall risk.
  • Brain fog. THC slows attention and short-term memory [21]. For someone already struggling to think clearly, it can feel like the illness got worse.
  • Drowsiness. CBD and THC both cause sleepiness, more so with other sedating medicines [22].
  • Heart rate and standing up. THC can raise the heart rate and drop blood pressure on standing [21], which overlaps with the orthostatic intolerance of ME/CFS.
  • Liver. Prescription CBD can raise liver enzymes, especially with valproate, so blood tests are part of using it [22].
  • Seizures. Prescription CBD is approved for certain rare epilepsies [22], but that does not make plant products safe for seizures after encephalitis; mixed THC products have not been tested for that and seizure medicines interact with CBD.

Cannabis with steroids, IVIG, antiseizure medicines, antidepressants and MS drugs

Tap each group of medicines on your current list; its note opens below. Nothing here replaces a pharmacist’s check of your own prescriptions.

Steroids (methylprednisolone, prednisone)

No well-described direct interaction, but high-dose steroids already disturb sleep, mood and blood sugar, and adding THC makes it hard to tell which is causing what. During an acute course, ask the treating team before adding anything.

IVIG and plasma exchange

These are hospital treatments for an active attack. That is not the time to start cannabis; headaches and dizziness after IVIG would also be harder to read.

Antiseizure medicines (clobazam, valproate and others)

CBD is broken down by the liver enzymes CYP3A4 and CYP2C19. On the label of prescription CBD, it raises levels of clobazam’s active product, which deepens sleepiness, and taken with valproate it raises liver enzymes [22]. Any CBD product needs your neurologist’s agreement and, often, blood tests.

Gabapentin and pregabalin

Both cause drowsiness and dizziness on their own. Together with THC or CBD the effects add up, and so does the risk of falls.

Benzodiazepines (clonazepam, lorazepam, diazepam)

Additive sedation and slowed breathing at higher doses. Clobazam, from the antiseizure group, is a benzodiazepine as well and has a direct interaction with CBD.

Antidepressants

Some are processed by the same liver enzymes as CBD, so levels can change; sedating ones add to drowsiness. Tricyclics, sometimes used for nerve pain, can add to a fast heart rate with THC.

Opioid pain medicines

Combined sedation and slowed breathing are the main concern, especially at night. Never change an opioid dose on your own because cannabis seems to help.

MS disease-modifying therapies

Several of these drugs can affect the liver or the heart rhythm, and some are handled by the same liver enzymes as CBD. The neurologist who prescribes your therapy decides whether cannabis fits next to it; more on cannabis and multiple sclerosis.

→ Who should not use cannabis · How the form of use changes things

Who should not use cannabis with encephalomyelitis

Some of these lines are firm, and some mean “only with the specialist who treats you”.

  • Children and teenagers. ADEM is most common in childhood, and there is no research on cannabinoids for it at any age. THC affects the developing brain; any decision belongs to the child’s neurologist.
  • During an acute attack or a hospital stay. The priority is steroids, IVIG or plasma exchange and close monitoring.
  • Pregnancy and breastfeeding. THC reaches the baby, and there is no evidence of safety.
  • A history of psychosis or schizophrenia, in you or a close relative. THC can trigger or worsen it.
  • Severe balance problems or frequent falls. Dizziness from THC adds to the risk.
  • Weak swallowing or breathing. Smoke and vapor go straight to airways that are already struggling.
  • Anyone who drives, operates machinery or cares for others alone soon after a dose.

→ How to raise it with your neurologist

Smoked, vaped, eaten, under the tongue or on the skin: what each form avoids and what stays

Cannabis is not only smoked, and the form changes some risks but not others. Smoke and vapor affect the airways; any form that gets THC into the blood brings the same effects on balance, thinking, sleepiness, the liver and other medicines. The table sorts what each form leaves behind and what it keeps; choosing a form is a conversation with the physician, not a recommendation from this page.

Forms of cannabis: what changes and what does not
FormWhat it avoidsWhat stays the same
Smoking: joints, pipes, bongsNothing in particularSmoke irritates airways; a concern with weak breathing or swallowing. THC effects as below.
Vaping: dry-herb vaporizers, oil pens, dabbingBurning plant materialHot aerosol still passes the same airways. Concentrates carry high THC.
Edibles, drinks, capsulesThe airwaysEffect starts late and lasts hours; a second helping taken too early is a common cause of taking too much. Passes the liver first.
Tinctures and sprays under the tongueThe airwaysAbsorption varies a lot between people. Same interactions and sedation.
Creams and balmsMost effects on the whole bodyAct mostly where applied. The CBD cream study was in mice, not a reason to expect relief in people [15].
Transdermal patchesThe airways and the stomachDeliver cannabinoids into the blood, so drowsiness and interactions apply as with any oral form.

Prescription cannabinoid medicines are a separate category: dronabinol and nabilone (synthetic THC-like drugs) and Epidiolex (purified CBD for certain epilepsies) come from a pharmacy with a prescription, at fixed doses [22] [21]. They are not what a medical marijuana card gives access to, and a card does not replace a prescription for them.

→ Bring these questions to your appointment

Is medical cannabis worth raising with your neurologist for encephalomyelitis?

It is worth raising when a specific symptom is the problem, such as stiffness, nerve pain or poor sleep, and when you go in knowing how thin the evidence is for your type. In short:

  • What is known: in mice and rats with a lab model of MS, cannabinoids made the disease milder.
  • What is not: whether that happens in people with ADEM, ME/CFS or autoimmune encephalomyelitis, at what dose, and with what side effects.
  • What to discuss: the one symptom you most want help with, your full medicine list, and how you would both judge whether it works.
Evidence for cannabis, by type
TypeEvidence levelWhere to read more
Lab model (EAE)Animal and cell studies onlyThe studies on this page
MS (encephalomyelitis disseminata)Studies in people existCannabis and MS
ADEM, autoimmune formsNo studies in peopleWhat science does not know
ME/CFSNo studies in peopleAbout ME/CFS

The symptoms people most often ask about each have their own evidence: stiffness and spasticity on cannabis and muscle spasms, nerve pain on cannabis and chronic pain, and sleep on cannabis and insomnia.

Build your question list

  1. Given my type of encephalomyelitis, is there any evidence cannabis could help the symptom that bothers me most?
  2. Could cannabis interact with any of my current medicines?
  3. Would THC make my balance or my fall risk worse?
  4. Could it make my brain fog, thinking or memory worse?
  5. If we try it, does a CBD-only or a THC-containing product make more sense for me?
  6. How will we tell after a month whether it is helping, and what do we do if it is not?
  7. Which side effects mean I should stop and call you?
  8. Can I drive or work safely on days I use it?

An evaluation makes sense if

Your diagnosis is settled and the acute phase is behind you. One symptom, such as spasms, nerve pain or sleep, keeps limiting your days despite standard care. Your neurologist knows, or you are ready to tell them. You understand that the research for your type is in animals.

It is not the right step if

You have new or worsening symptoms that nobody has assessed. You are in or just out of hospital for an attack. You hope cannabis will replace steroids, immune therapy or an MS medicine. The patient is a child. You are pregnant or have had psychosis.

Encephalomyelitis itself almost never appears by name on a state’s list of qualifying conditions, while multiple sclerosis is listed in many programs. Most people with encephalomyelitis who qualify do so through a listed symptom or a related diagnosis, and the physician matches your records to the exact wording of your state’s list.

Routes through your symptoms

Multiple sclerosis

Named directly in many programs if your diagnosis is MS.

Cannabis and MS

Debilitating condition clause

Some states let a physician certify a condition that is not listed.

Rules by state

What to check on your state’s page before you apply
TopicWhat to look for
Legal statusWhether the state runs a medical program, and whether recreational sales also exist
Qualifying conditionsThe exact wording: MS, spasms, chronic pain, seizures, or a debilitating-condition clause
Possession limitsHow much a registered patient may buy and hold
TaxesWhether patients pay less tax than other buyers
CultivationWhether patients may grow plants at home

All of this is set out state by state on medical marijuana laws by state.

Minor patients and caregiver rules

State programs treat minors separately. Where they allow minor patients at all, a parent or legal guardian usually has to consent and register as the patient’s caregiver, and some states require certification from a second physician or limit minors to low-THC products. Many states also let an adult who cannot shop for themselves name a registered caregiver. These rules, forms and fees differ from state to state and are listed on each state’s laws page.

Work, driving, firearms and privacy with a medical card

Driving

A card never makes driving after THC legal. With slowed reactions, vision problems or weakness from encephalomyelitis, THC adds to the impairment you already work around. Do not drive after a dose.

Work and drug tests

Some states protect registered patients from being fired for off-duty use; many do not, and federal jobs and safety-sensitive roles follow federal rules. Check your state’s page and your employer’s policy before you apply.

Firearms

Under federal law, a person who uses marijuana is barred from buying or owning firearms, and the federal purchase form, ATF Form 4473, asks about it directly, whatever your state allows [23].

Privacy

The evaluation is a telemedicine appointment, a medical consultation held online, and its records are protected health information under HIPAA. State patient registries are confidential and not published.

→ Common questions about medical cards

How to get a medical card online, first time or renewal

Everything happens from home: a short application, an appointment with a physician licensed in your state, and the paperwork your state asks for.

1. Apply online

About five minutes: your diagnosis, symptoms and medicines. Keep your neurologist’s letter or MRI report handy.

2. See the physician

About fifteen minutes with a physician licensed in your state. You agree the time together; keep an hour free.

3. Get your recommendation

If approved, it can be ready in as little as fifteen minutes after the appointment, depending on your state. Then register with the state where required.

4.6out of 5 on Google

Across 250 reviews from patients in the states where we are licensed. We do not sort them by score and do not hide the low ones.

  • 150,000+patients evaluated – everyone who has been through an appointment with us, in every state where we are licensed
  • Since 2017doing only this: online evaluations for medical cannabis programs, and nothing else on the side

Your signed recommendation and appointment history stay in your account, where you can download them again. Renewal works the same way in a shorter form; start it before your current card expires. Price, renewal and what the card covers are explained on how the medical card works, and the fee for your state is shown before you pay. Veterans and patients with low income have their own routes: veterans and low-income patients. The medical content of this page is reviewed by the Dr. Weedy medical team.

Encephalomyelitis and medical cannabis: frequently asked questions

What is autoimmune encephalomyelitis?

It is inflammation of the brain and spinal cord caused by the immune system attacking the nervous system, often with a measurable antibody such as MOG-IgG (MOGAD) or AQP4-IgG (NMOSD). It is diagnosed with MRI, spinal fluid and blood antibody tests, and treated with steroids, plasma exchange and longer-term immune therapy.

What causes encephalomyelitis?

Usually the immune system reacting after an infection, as in ADEM, or an autoimmune disease. Rarely it follows a vaccine. ME/CFS often begins after an infection too, though the reason it persists is still unclear.

Is encephalomyelitis contagious?

No. The inflammation and ME/CFS do not spread between people. The infection that triggered it can be contagious, and mosquito-borne forms spread through bites.

Is myalgic encephalomyelitis a neurological condition?

Yes. The WHO classifies it among diseases of the nervous system, and the US code is G93.32 [3]. It also affects the immune system, energy metabolism and circulation, which is why it is described as multisystem.

Can myalgic encephalomyelitis be cured?

There is no cure or approved drug yet. Many people improve with pacing and treatment of sleep, pain and dizziness, some substantially, but full recovery in adults is uncommon.

Is ME/CFS a disability?

It can be. When symptoms prevent a person from working, ME/CFS can support a disability claim in the United States; the claim rests on documented limits in daily function, so a diagnosis from a physician and records of PEM matter.

What is the ICD-10 code for encephalomyelitis?

It depends on the type: G04.00 to G04.02 for ADEM, G04.81 for other named forms, G04.90 when unspecified, G93.32 for ME/CFS, and G35.A to G35.D for multiple sclerosis since October 2025 [3].

Can CBD help encephalomyelitis?

Only animal results exist. In mice with a lab model of MS, CBD by mouth, by injection or as a skin cream made the disease milder [12] [15]. No study has tested CBD in people with ADEM, ME/CFS or autoimmune encephalomyelitis, so whether it helps them is unknown.

Is encephalomyelitis a qualifying condition for medical marijuana?

Rarely by name. Patients usually qualify through MS, chronic pain, severe muscle spasms, seizures or a debilitating-condition clause, depending on the state’s list. The physician checks your records against that list at the evaluation.

What is progressive encephalomyelitis with rigidity and myoclonus?

PERM is a rare autoimmune disease in the stiff person spectrum, often with antibodies against the glycine receptor. It causes muscle stiffness, painful spasms, sudden jerks and brainstem symptoms, and is treated with immune therapy and medicines that relax muscles.

Are hemp CBD or delta-8 products the same as state-program cannabis?

No. Hemp-derived CBD and delta-8 products are sold outside medical programs, with uneven labeling and testing. State-program products are tested and labeled for THC and CBD content under state rules, and a medical card is what gives you access to them.

More research on cannabis and encephalomyelitis

This page cites a selection of studies. Our research library holds every study we track on cannabis and encephalomyelitis, from laboratory work to clinical trials, and lets you filter them by cannabinoid, study type and year.

studies
86
in people
44
clinical trials
0

See the studies on encephalomyelitis

Share your experience

Leave an anonymous messageTell us what this page failed to answer, or where we got something wrong. It goes to the team, not onto the page, and no account or email is needed.
Share your storyA longer account of living with this condition, written for the people who arrive at this page next. Published with your first name, or anonymously if you ask.
Write a public commentAsk a question, correct us, or answer somebody else’s question at the foot of this page. Comments are public once they clear moderation.Add a comment

    💬

    How else can we help you?

    Tell us what you’d like to see, learn, or get from us next.

    🕶️
    100% anonymous — share what’s on your mind
    We will only use it if we need to follow up on your message.

      💬

      Share Your Story with the Dr. Weedy Community

      Your positive, negative, or neutral experience can really help others. Feel free to share it in a few clear, short sentences.

      🕶️
      Your contact details are encrypted and will never be shared publicly

      References

      23 sources
      1. 1. National Institute of Neurological Disorders and Stroke. Acute Disseminated Encephalomyelitis. 2024.
      2. 2. National Institute of Neurological Disorders and Stroke. Encephalitis. 2024.
      3. 3. Centers for Medicare & Medicaid Services. ICD-10 Codes, FY 2026 ICD-10-CM. 2025.
      4. 4. Centers for Disease Control and Prevention. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). 2024.
      5. 5. National Multiple Sclerosis Society. What Is MS?. 2025.
      6. 6. Centers for Disease Control and Prevention. About Eastern Equine Encephalitis Virus. 2024.
      7. 7. ASPCA Animal Poison Control Center. Marijuana. 2024.
      8. 8. Institute of Medicine (National Academies). Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. 2015.
      9. 9. Encephalitis International. Information and support for people affected by encephalitis. 2025.
      10. 10. Nichols JM, Kaplan BLF The CB1 Receptor Differentially Regulates IFN-γ Production In Vitro and in Experimental Autoimmune Encephalomyelitis. Cannabis Cannabinoid Res · 2021 · preclinical DOI: 10.1089/can.2020.0046 PMID: 33998867
      11. 11. Kong W, Li H, Tuma RF, et al. Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS. Cell Immunol · 2014 · preclinical DOI: 10.1016/j.cellimm.2013.11.002 PMID: 24342422
      12. 12. Nichols JM, Kummari E, Sherman J, et al. CBD Suppression of EAE Is Correlated with Early Inhibition of Splenic IFN-γ + CD8+ T Cells and Modest Inhibition of Neuroinflammation. J Neuroimmune Pharmacol · 2021 · preclinical DOI: 10.1007/s11481-020-09917-8 PMID: 32440886
      13. 13. Yang X, Bam M, Nagarkatti PS, et al. Cannabidiol Regulates Gene Expression in Encephalitogenic T cells Using Histone Methylation and noncoding RNA during Experimental Autoimmune Encephalomyelitis. Sci Rep · 2019 · preclinical DOI: 10.1038/s41598-019-52362-8 PMID: 31673072
      14. 14. Al-Ghezi ZZ, Busbee PB, Alghetaa H, et al. Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome. Brain Behav Immun · 2019 · preclinical DOI: 10.1016/j.bbi.2019.07.028 PMID: 31356922
      15. 15. Giacoppo S, Galuppo M, Pollastro F, et al. A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis. Daru · 2015 · preclinical DOI: 10.1186/s40199-015-0131-8 PMID: 26489494
      16. 16. Carrillo-Salinas FJ, Navarrete C, Mecha M, et al. A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis. PLoS One · 2014 · preclinical DOI: 10.1371/journal.pone.0094733 PMID: 24727978
      17. 17. Kheirdeh M, Koushkie Jahromi M, Brühl AB, et al. The Effect of Exercise Training and Royal Jelly on Hippocampal Cannabinoid-1-Receptors and Pain Threshold in Experimental Autoimmune Encephalomyelitis in Rats as Animal Model of Multiple Sclerosis. Nutrients · 2022 · preclinical DOI: 10.3390/nu14194119 PMID: 36235771
      18. 18. Giardini AC, Evangelista BG, Sant’Anna MB, et al. Crotalphine Attenuates Pain and Neuroinflammation Induced by Experimental Autoimmune Encephalomyelitis in Mice. Toxins (Basel) · 2021 · preclinical DOI: 10.3390/toxins13110827 PMID: 34822611
      19. 19. Contarini G, Franceschini D, Facci L, et al. A co-ultramicronized palmitoylethanolamide/luteolin composite mitigates clinical score and disease-relevant molecular markers in a mouse model of experimental autoimmune encephalomyelitis. J Neuroinflammation · 2019 · preclinical DOI: 10.1186/s12974-019-1514-4 PMID: 31221190
      20. 20. Li Y, Zhou D, Ren Y, et al. Mir223 restrains autophagy and promotes CNS inflammation by targeting ATG16L1. Autophagy · 2019 · preclinical DOI: 10.1080/15548627.2018.1522467 PMID: 30208760
      21. 21. U.S. Food and Drug Administration. Marinol (dronabinol) prescribing information. 2017.
      22. 22. U.S. Food and Drug Administration. Epidiolex (cannabidiol) prescribing information. 2018.
      23. 23. Bureau of Alcohol, Tobacco, Firearms and Explosives. ATF Form 4473, Firearms Transaction Record. 2023.
      0 Comments
      Security check required

      Our security system needs to verify your connection. Please reload the page and complete the quick verification — your details are safe and nothing was lost.